Company / Gross Profit
Progyny Gross Profit History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$304.5M
FY2025
5-year range
$112.1M / $304.5M
FY2021-FY2025
Trend
+20.2%
vs FY2024
Sector context
#67 of 95
Health Care
What the data says
At $304M, Progyny's gross profit ranks #67 of 95 in the Health Care sector. Gross Profit has increased for 8 consecutive years, from $7M in FY2017 to $304M in FY2025.
Based on SEC 10-K filings.
$304M in FY2025 with a 5-year CAGR of +34.2%.
Improved from $239M to $304M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +22.1%
- 5-Year CAGR
- +34.2%
- 10-Year CAGR
- -
Sector benchmark
#67 of 95 in Health CareTop 71% of 95This company $304.5M Sector average $1.9B
▼
-83.8% below sector average
Key checks
Key Insights
- Progyny's gross profit has grown for 8 consecutive years.
- 5-year CAGR of +34.2%, indicating consistent growth.
- In FY2025, gross profit increased 20.2% year-over-year.
- Ranks #67 out of 95 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $304.5M | +20.2% |
| FY2024 | $253.4M | +6.1% |
| FY2023 | $238.8M | +42.7% |
| FY2022 | $167.3M | +49.2% |
| FY2021 | $112.1M | +60.1% |
| FY2020 | $70.1M | +54.0% |
| FY2019 | $45.5M | +134.2% |
| FY2018 | $19.4M | +162.6% |
| FY2017 | $7.4M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026